These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 1834876
21. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides]. Harada K, Orita T, Abiko S, Aoki H. Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799 [Abstract] [Full Text] [Related]
22. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma. Takeda S, Katoh H, Takaki A, Okamoto K, Ohsato K. Thromb Res; 1990 Jan 15; 57(2):289-300. PubMed ID: 2156347 [Abstract] [Full Text] [Related]
23. [Wound healing, blood coagulation and fibrinolysis during operations involving gastric cancer surgery]. Gando S, Kamiya K, Makise H, Tedo I, Nakanishi Y. Nihon Geka Gakkai Zasshi; 1989 Jan 15; 90(1):59-63. PubMed ID: 2565016 [Abstract] [Full Text] [Related]
24. Enhanced ex vivo proteolysis of plasma von Willebrand factor in disseminated intravascular coagulation. Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A. Blood Coagul Fibrinolysis; 1992 Oct 15; 3(5):583-8. PubMed ID: 1450324 [Abstract] [Full Text] [Related]
25. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA, Dempfle CE, Matsuda M, Heene DL. Thromb Haemost; 1997 Sep 15; 78(3):1069-78. PubMed ID: 9308756 [Abstract] [Full Text] [Related]
26. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation. Matsumoto T, Wada H, Nobori T, Nakatani K, Onishi K, Nishikawa M, Shiku H, Kazahaya Y, Sawai T, Koike K, Matsuda M. Clin Appl Thromb Hemost; 2005 Oct 15; 11(4):391-400. PubMed ID: 16244764 [Abstract] [Full Text] [Related]
27. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism]. Yamasawa F, Hasegawa N, Asano K, Sayama K, Fujita H, Urano T, Aoki T, Ishizaka A, Kanazawa M, Kawashiro T. Kokyu To Junkan; 1992 Jul 15; 40(7):685-90. PubMed ID: 1387724 [Abstract] [Full Text] [Related]
28. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients. Geenen RW, Delaere KP, van Wersch JW. Eur J Clin Chem Clin Biochem; 1997 Feb 15; 35(2):69-72. PubMed ID: 9056745 [Abstract] [Full Text] [Related]
30. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan 15; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
31. Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis. Kumano O, Ieko M, Komiyama Y, Naito S, Yoshida M, Takahashi N, Ohmura K, Hayakawa M. Int J Lab Hematol; 2021 Aug 15; 43(4):813-820. PubMed ID: 33301236 [Abstract] [Full Text] [Related]
33. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T. Blood Coagul Fibrinolysis; 1994 Oct 15; 5(5):829-32. PubMed ID: 7865691 [Abstract] [Full Text] [Related]
34. Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization. Kumano H, Suehiro S, Hattori K, Shibata T, Sasaki Y, Hosono M, Kinoshita H. Ann Thorac Surg; 1999 Oct 15; 68(4):1252-6. PubMed ID: 10543488 [Abstract] [Full Text] [Related]